Europe Laboratory Developed Tests Market Analysis Report 2024-2030: Rising Cancer Cases Fuel Demand, Advancements in Molecular Diagnostics Propels Expansion
March 18, 2024 04:45 ET
|
Research and Markets
Dublin, March 18, 2024 (GLOBE NEWSWIRE) -- The "Europe Laboratory Developed Tests Market Size, Share & Trends Analysis Report By Technology (Immunoassay, Molecular Diagnostics), By Application...
Laboratory Developed Test Market Size to Surpass US$ 16,404.2 Million by 2034: Fact.MR. Report
March 14, 2024 05:56 ET
|
FACT.MR
Rockville , March 14, 2024 (GLOBE NEWSWIRE) -- The laboratory developed tests market is estimated to be valued at US$ 8,698.6 million in 2024. The market is projected to expand at a CAGR of 6.5%...
ProPhase Labs Announces Data Presentation for its BE-Smart Esophageal Cancer Test
March 13, 2023 08:00 ET
|
ProPhase Labs, Inc.
Presentation to be given in Collaboration with the Mayo Clinic at the United States and Canadian Academy of Pathology (USCAP) Annual Meeting Company’s findings to be presented in a headline Poster...
Insights on the Laboratory Developed Tests Global Market to 2033 - Escalating Demand for Personalized Medicine and Increasing Use of Modern Technology Drives Growth
February 13, 2023 06:28 ET
|
Research and Markets
Dublin, Feb. 13, 2023 (GLOBE NEWSWIRE) -- The "Laboratory Developed Tests Market by Technology, by Application, and by Region - Global Forecast to 2023-2033" report has been added to ...
Laboratory Developed Tests Global Market Report 2022: Increasing Demand for in Vitro Diagnostic Tests That Are Currently Unavailable in the Market Fuels Innovation
January 23, 2023 09:13 ET
|
Research and Markets
Dublin, Jan. 23, 2023 (GLOBE NEWSWIRE) -- The "Laboratory Developed Tests Market Size, Share & Trends Analysis Report By Technology (Immunoassay, Molecular Diagnostics), By Application...
Laboratory Developed Test Market estimated to surge ahead at a CAGR of 6.4% by the end of 2032 – Persistence Market Research
June 14, 2022 10:30 ET
|
Persistence Market Research
New York, June 14, 2022 (GLOBE NEWSWIRE) -- Owing to the high prevalence of chronic conditions & genetic disorders, rise in the incidence of infectious & autoimmune diseases, and increasing...
U.S. Market for Direct-to-Consumer (DTC) Laboratory Testing 2022-2026, Featuring Profiles of Color Genomics, EasyDNA, Everlywell, MyMedLab and Quest Diagnostics
June 10, 2022 07:08 ET
|
Research and Markets
Dublin, June 10, 2022 (GLOBE NEWSWIRE) -- The "U.S. Market for Direct-to-Consumer (DTC) Laboratory Testing" report has been added to ResearchAndMarkets.com's offering. Direct to consumer laboratory...
Lucid Diagnostics Announces Pricing of Initial Public Offering
October 13, 2021 22:15 ET
|
Lucid Diagnostics Inc.
NEW YORK, Oct. 13, 2021 (GLOBE NEWSWIRE) -- Lucid Diagnostics Inc. (Nasdaq: LUCD) (“Lucid”) a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (Nasdaq:...
Global Laboratory Developed Test Market to 2028 - COVID-19 Impact and Analysis
September 27, 2021 06:33 ET
|
Research and Markets
Dublin, Sept. 27, 2021 (GLOBE NEWSWIRE) -- The "Global Laboratory Developed Test Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Clinical Biochemistry, Critical Care,...